An accomplished Business Development, Sales and Product Manager with a track record of success in performance focused and technically challenging scientific environments. Offers a winning combination of commercial experience, technical ability and sales expertise. Has the personal qualities required to develop a detailed understanding of customer needs, and to develop long-term client relationships. Proven experience from a wide variety of pharma/biotech clients across the UK, Northern Europe, Scandinavia.

Education: University of Leeds, Sheffield Hallam University, Anstey Martin High School

Specialties: Life Science, strategic and tactical planning, public speaking, process development, chromatography.

Alexey Shilov was born in 1969. After school leaving and servicing the Army he graduated Institute of culture and University of business and management in Moscow. He worked in different commercial and state enterprises. Last 4 years Shilov has been working in pharmaceutical business. He is the chairman’s advisor at JSC “Pharmasyntez”, Irkutsk.

Vitali Proutski has over 18 years of professional experience in molecular and cell biology, research informatics and biostatistics. Until recently, he has been responsible for all operational activities of the Bioinformatics & Biostatistics Department of Almac Diagnostics (BU of Almac Group Ltd), a biomarker discovery, diagnostic assay development and bioinformatics consultancy solutions provider. In this role, Vitali has established the data analysis consultancy capabilities and has been involved in a number of internationally sponsored biomarker discovery projects, as well as in developing and validating robust and clinically applicable biomarker assays. In addition to the operational responsibilities, Vitali, along with other members of the senior management team, has been defining and developing an overall commercial products and services strategy of the company.

Prior to joining Almac, Vitali spent several years working in the UK and the Netherlands for Organon, a pharmaceutical company. There he was first responsible for setting up the UK Bioinformatics team supporting projects in Target Discovery and Lead Optimization, and later for the application of “omics” and computational technologies to the identification and characterization of compound toxicity/safety issues in Selection Phase of Lead Optimization. Vitali has also worked for the UK Medical Research Council and Oxagen Ltd., a small UK biotech company.

Vitali graduated with a Medical Degree (Cum Laude) from the 1^st Medical University, St. Petersburg, Russia, and also received DPhil Degree in Computational Biology from the University of Oxford, UK.

Gennady Shirshov has been in the current position of Executive Director of SPFO (Society of Professional Pharmaceutical Organizations) since its establishment in April 2002. Bringing together companies representing the entire value chain in the pharmaceutical sector, SPFO is a unique platform for a proactive dialogue both within the sector and between business and the Government. SPFO enjoys excellent sector resources (legal and professional) and is a proactive partner of the Government in establishing quality based pharmaceutical sector and healthcare in Russia.

Mr. Shirshov is a member of (i) the Russian Government Council for the Development of the National Pharmaceutical Sector, and (ii) Expert/Advisory Councils in various federal-level agencies and ministries related to the pharmaceutical sector. He also leads a number of initiatives such as the National Anti-Counterfeiting Campaign.

Prior to SPFO, Mr. Shirshov worked for British American Tobacco (BAT Uzbekistan) as Logistics Manager and MRP II Project Manager (1994-2001), and United Nations Office in Uzbekistan.

Gennady Shirshov is married and has two children.

Jay Nadkarni has over 20 years of experience in the Biotechnology and Pharmaceutical industry in the United States, Europe, Latin America and Asia with a focus on New Product Commercialization, Business Development and Global Marketing / Distribution. He is an expert on international services for Co-development, Technology Transfers, Strategic Marketing and Due Diligence with emphasis on Emerging Markets.  His company, Ambiance Ventures, has developed an innovative model for New Product Technology Transfers based on connecting Life Science companies with worldwide co-development partners who are seeking innovative products. He not only creates strategic consortiums between global companies, but also coordinates and leads the clinical trials and marketing effort – a total hand-holding, supportive process through long-term relationships with private and public entities across continents. Market Assessment and Due Diligence on technical capabilities of foreign partners are the cornerstones of his sustained success. During his career, Jay has provided leadership in product commercialization during all stages of clinical studies for new molecules and biopharmaceuticals in Developed and Emerging markets. He has led Product and Business Development teams from bench-to-customer by working closely with internationally renowned Key Opinion Leaders and Corporate cross-functional teams. Ambiance Ventures has offices in USA, Europe, Latin America and Asia. Jay’s team comprises of industry-recognized experts with unique abilities to validate and bridge client needs with pragmatic solutions and offer actionable proposals for measuring returns on investment.

1998 – North-West Academy of Public Administration in Saint-Petersburg postgraduate. Since 2008 – Deputy Director General, Head of the Investment Programs Department, Kaluga Region Development Corporation (OJSC). Since July 2009 – Director, Regional Development Agency of the Kaluga Region. Since June 2011 – Deputy Minister – head of the investment department, Ministry for economic development of Kaluga region. Mr. Abramov directly took part in forming of investment policy and cluster strategy of Kaluga region. He is personally responsible for conditions of placing productions of world-leading enterprises on the territory of Kaluga region.

Professional activity

From June 2011 she is heading the position of Director Regulatory Affairs and Healthcare Policy in Association of International Pharmaceutical Manufacturers.

Elena is graduated from Russian State Medical University. She has scientific (PhD) decree in medicine.

Started her career in pharmaceutical industry in 2001, she sequentially took different positions in international pharmaceutical company in different departments: sales, marketing, new product development & regulatory affairs, business development. During last four years before to join AIPM, Elena took position of Head business development, quality control and pharmacovigilance.

Phone: +7(812)-234-2950.  Fax: +7(812)-747-26-27. E-mail: Elena.Fedorova@pharminnothech.com

MAIN PHONE NUMBER: Phone (home): +7(812)-495-37-96, Mobile: +7-962-690-21-42 

EDUCATION

Ph.D. in Chemistry/Petroleum Chemistry and Organic Catalysis, Moscow State University, Moscow, Russia, 2003, Title: Vanadium peroxocomplexes as catalysts of sulfides oxidation. Research Advisor: Prof. A.V. Anisimov.

B.S./M.Sci. in Chemistry/Petroleum Chemistry and Organic Catalysis, Moscow State University, Moscow, Russia, 2000, Diploma specialist in Petroleum Chemistry,with distinction (Excellent). Title: Oxidation of organic sulfides using hydrogen peroxide catalysed by peroxovanadium complexes. Research Advisor: Prof. A.V. Anisimov.

PROFESSIONAL EXPERIENCE

Head of IT Department  Chemical Pharmaceutical Academy Russia, 2011- present

Senior Researcher        Saint-Petersburg State Institute of Technology (Technical University), 2010-2011

Lecturer                        Department of Chemistry, Chemical Pharmaceutical Academy Russia, 2004-present

Research Scientist        Department of Chemistry, Chemical Pharmaceutical Academy Russia, 2004-present

Visiting Scientist           Department of Chemistry, Friedrich-Schiller-University of Jena, Germany, 2003-2004

Research Scientist        Department of Chemistry Moscow State University, Russia, 2000-2003

HONORS & AWARDS

First Prize for Educational Innovation Project (EIP), Chemical Pharmaceutical Academy, 2007

Research Fellowship (German Academic Exchange Service, DAAD), 2003

Young Scientist Student Award by Moscow State University, 2002 

 RESEARCH INTERESTS

Vanadium complexes as therapeutic agents for diabetes

Synthesis of ligands for transition metal ions

Solid State Synthesis and Crystal Growth

Oil desulphurization chemistry

Pharmaceutical Chemistry

Environmental Chemistry

Asymmetric Catalysis

Analytical Chemistry

Bioinformatics

Karina Chichkanova is a partner of international law firm Salans.  Karina has worked in Salans’ St. Petersburg office since it was founded in 1993. She is a leading PPP and real estate expert in St. Petersburg and has gained a high standing among clients and the rofessional community. Karina heads Salans St. Petersburg’s real estate and Russian PPP practices.

Karina Chichkanova has extensive experience in general corporate and commercial law, real estate and construction law, and infrastructure issues. She is an advisor to leading Russian and international corporate clients with regard to corporate and civil law in Russia, real estate, foreign investment, acquiring property rights, leasing properties, and joint investment agreements both in St.Petersburg and other regions. Karina‘s expertise also enables her to represent Russian and international pharmaceutical and healthcare companies. Karina has authored various articles and given numerous presentations on PPP, real estate, construction, privatization and investment issues.

In 2011,  Best Lawyers named Karina the best lawyer in Real Estate in St.Petersburg among 19 lawyers throughout Russia (the  list was published in Vedomosti newspaper on June 16, 2011).

In 2010,  Best Lawyers named Karina among the top 30 corporate lawyers in Russia (the list was published in Vedomosti newspaper on June 3, 2010). Legal 500 named Karina Chichkanova “one of the leading professionals in the
real estate market”, and also one of the most recommended lawyers in St.Petersburg in 2009. The same edition acknowledged her “impressive experience” in PPP projects.

Karina has actively participated since 2002 in international investment
conventions and exhibitions, such as ExpoReal and MIPIM. She has been a
member of the official St. Petersburg delegation and a legal consultant on
investment issues during these exhibitions.

Karina graduated from St. Petersburg State University (Law faculty) in 1990. She
speaks English fluently.

E: kchichkanova@salans.com    T: +7 812 325 8444

-CEO of FinnMedi since 1995, Coordinator of two national clusters, Finland

-Sales Manager at Esso/ExxonMobil 2001-2005

-Tampere University of Technology, MS in Engineering

FinnMedi Oy is a representative of two national clusters of Finland: HealthBIO and Well-being.

FinnMedi is an internationally operating company. FinnMedi provides services related to business development and clinical research in the Life Sciences sector. Trough FinnMedi their customers have access to the leading scientific know-how, experienced researchers, university hospitals, life science companies, as well as public and venture capital funding. FinnMedi is a coordinator of two national clusters of Finland: HealthBIO and Health and Well-being. The HealthBIO cluster strives to increase, internationalise and generate new biotechnology business in Finland. A further aim is to support the creation of service enterprises derived from higher education research, and the transfer of technology from higher education institution to businesses. Finnish Health and Well-being Cluster is a development platform for health and well-being services and associated technologies.

Born May 15, 1977 in Starokonstantinov, the Khmelnitski Region. Since 1978 lived in Pskov. In 1994 graduated from the secondary school №24.

In 1999 graduated from the Finance Academy under the Government of the Russian Federation (specialty “Finance and credit”, specialization – “Tax investigations”).

Started his career in 1998 as an expert of the Legal Economic Expertise Department in the Federal Tax Police Service of the Russian Federation.

2001 – 2003 worked in the Expert Department of the Federal Tax Police Service of the Russian Federation over Moscow and Moscow Region.

In 2003 was appointed Deputy Head of the Legal Economic Expertise Department of the Moscow Region Central Internal Affairs Directorate.

2004 – 2007 – Deputy Director General, Taxation and Law Department Director in “Rosexpertiza”, a large-scale audit and consulting company.

In November 2007 was invited to take up the position of the firs Deputy Director General in Kaluga Region Development Corporation (OJSC), and in 2008 became the CEO of the company.

In 2008 graduated from Saint-Petersburg University of the Ministry of the Interior (specialty “Jurisprudence”).

In October 2008 was appointed Deputy Minister – Head of the Investment Department of the Kaluga Region Ministry for Economic Development. 

Since 29.09.2009 – acting Minister for Economic Development of the Kaluga Region.

Since 11.01.2009 – Minister for Economic Development of the Kaluga Region.

Board member, Kaluga Region Development Corporation (OJSC).

Родился 13.05.1969 в Санкт-Петербурге.

В 1993 году окончил Санкт-Петербургский государственный медицинский Университет имени академика И.П. Павлова и клиническую ординатуру по специальности «Эндокринология».

В 1988 – 1989 годах проходил службу в Советской Армии.

В 1998 году получил степень MBA в Санкт-Петербургском международном институте менеджмента.

С 1994 года работает в компании «Ново Нордиск АС»: медицинский представитель московского представительства, региональный менеджер по Северо-Западному региону; с 1997 года – региональный директор по продажам в России.

В октябре 2001 года Сергей Смирнов возглавил Представительство компании «Ново Нордиск» в России и странах СНГ, координируя деятельность компании в 12 стран СНГ и Монголии. Сергей Смирнов стал самым молодым вице-президентом одной из крупнейших компании на фармрынке.

Кроме того, в течение двух лет Сергей являлся членом Совета Директоров «Ассоциации Международных Фармацевтических Организаций». В 2008 году избран председателем Комитета Ассоциации Европейского Бизнеса.

Сергей являлся единственным представителем от России в Международной рабочей группе IDF (Международной Диабетической Федерации) по принятию специальной резолюцию ООН по сахарному диабету.

Занимая столь важные должности, Сергей продолжает совершенствовать свои знания. В 2006 году получил степень кандидата социологических наук в Ростовском государственном педагогическом университете, а в 2008 году окончил Социально-правовой институт экономической безопасности по специальности «Юриспруденция».

Женат и воспитывает двоих сыновей.

Born on 29 April, 1968 in Obninsk, Kaluzhsky region Graduated with honours from the Plechanov Russian Academy of Economics 1991-1996 – Commercial Director, “Apex”, Moscow

1996-1999 – General Director, “РКC”, Moscow
2000-2006 – General Director, ZAO “Medbiopharmacentre”, Moscow

2006-2007 –General Director, ООО “Radiopreparat”, Moscow

14 December 2007 appointed Director of the Chemical and Technological Complex and Bioengineering Technologies, Minpromenergo, Russia, by the Ministry of Industry and Energy of the Russian Federation.

18 July 2008 appointed Director of the Chemical and Technological Complex and Bioengineering Technologies, Minpromtorg, Russia, by the Ministry of Industry and Energy of the Russian Federation.

Graduated from the 1^st Moscow Sechenov Medical Institute and the High School of International Business at the Academy of National Economy of Government of Russian Federation;

MD, PhD, MBA

Has more than 45 scientific publications, is the author of 3 inventions;

The member of the “Guild of Professional Pharmaceutical Marketing” and a member of the Board of the Russian Association of Pharmaceutical Marketing (RAFM);

1982-2011 – Senior Researcher, Institute of Biomedical Problems; Regional manager of CJSC «Ezasibasi Health Care Products”; Commercial Director of the Representation of Knoll AG BASF Pharma; Head of the Representation of Orion Pharma International, STADA Pharma International GmbH; Marketing Director of  EGIS (Hungary) in Russia;Berlin-Chemie/Menarini Pharma in Russia; Deputy Director General, CSO of JSC Binnopharm, AFK Sistema.